Effects of valproate and carbamazepine monotherapy on neuroactive steroids, their precursors and metabolites in adult men with epilepsy

Journal of Steroid Biochemistry and Molecular Biology

Volumn 122, Issue 4, 2010, Pages 239-252

  Hill, Martin ^a,b   Zárubová, Jana ^c   Marusič, Petr ^d   Vrbíková, Jana ^a   Velíková, Marta ^a   Kancheva, Radmila ^a   Kancheva, Lyudmila ^a   Kubátová, Jana ^a   Dušková, Michaela ^a   Zamrazilová, Ludmila ^a   Kazihnitková, Hana ^a   Šimůnková, Kateřina ^a,e   Stárka, Luboslav ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Thomayer's Teaching Hospital   (Czech Republic)

^d UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^e CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Androstanes; Carbamazepine; Epilepsy; GC MS; Neuroactive steroids; Pregnanolone isomers; Valproate

Indexed keywords

17 HYDROXYPREGNENOLONE; 20ALPHA DIHYDROPROGESTERONE; 5ALPHA,20ALPHA TETRAHYDROPROGESTERONE; 7BETA HYDROXY PRASTERONE; ANDROGEN; ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTENEDIOL; ANDROSTERONE; CARBAMAZEPINE; ELTANOLONE; EPIANDROSTERONE; GONADOTROPIN; HYDROCORTISONE; HYDROXYPROGESTERONE; ISOPREGNANOLONE; PRASTERONE; PREGN 5 ENE 3BETA,20ALPHA DIOL; PREGNENOLONE; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; STEROID; TESTOSTERONE; UNCLASSIFIED DRUG; VALPROIC ACID; ANDROSTANE DERIVATIVE; ANTICONVULSIVE AGENT;

ADULT; ANDROGEN BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EPILEPSY; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; IMMUNOASSAY; MALE; MASS FRAGMENTOGRAPHY; MONOTHERAPY; STEROID METABOLISM; ANALOGS AND DERIVATIVES; BLOOD; METABOLISM;

ADULT; ANDROSTANES; ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GONADOTROPINS; HUMANS; MALE; PREGNENOLONE; SEX HORMONE-BINDING GLOBULIN; STEROIDS; TESTOSTERONE; VALPROIC ACID;

EID: 77957267976     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.06.003     Document Type: Article

References (67)

1. Kancheva R., Hill M., Novak Z., Chrastina J., Velikova M., Kancheva L., Riha I., Starka L. Peripheral neuroactive steroids may be as good as the steroids in the cerebrospinal fluid for the diagnostics of CNS disturbances. J. Steroid Biochem. Mol. Biol. 2010, 119(1-2):35-44.
2. Bixo M., Andersson A., Winblad B., Purdy R.H., Backstrom T., Progesterone 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res. 1997, 764(1-2):173-178.
3. Joels M. Steroid hormones and excitability in the mammalian brain. Front. Neuroendocrinol. 1997, 18(1):2-48.
4. Pimentel J. Current issues on epileptic women. Curr. Pharm. Des. 2000, 6(8):865-872.
5. Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 2003, 28(2):139-168.
6. Beyenburg S., Stöffel-Wagner B., Bauer J., Watzka M., Blumcke I., Bidlingmaier F., Elger C.E. Neuroactive steroids and seizure susceptibility. Epilepsy Res. 2001, 44(2-3):141-153.
7. Morrell M.J. Epilepsy in women: the science of why it is special. Neurology 1999, 53(4 Suppl. 1):S42-S48.
8. Edwards H.E., Burnham W.M., Mendonca A., Bowlby D.A., MacLusky N.J. Steroid hormones affect limbic afterdischarge thresholds and kindling rates in adult female rats. Brain Res. 1999, 838(1-2):136-150.
9. Edwards H.E., Burnham W.M., MacLusky N.J. Testosterone and its metabolites affect afterdischarge thresholds and the development of amygdala kindled seizures. Brain Res. 1999, 838(1-2):151-157.
10. Wise P. Estradiol exerts neuroprotective actions against ischemic brain injury: insights derived from animal models. Endocrine 2003, 21(1):11-15.
11. Bastianetto S., Ramassamy C., Poirier J., Quirion R. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res. Mol. Brain Res. 1999, 66(1-2):35-41.
12. Mao X., Barger S.W. Neuroprotection by dehydroepiandrosterone-sulfate: role of an NFkappaB-like factor. Neuroreport 1998, 9(4):759-763.
13. Jellinck P.H., Lee S.J., McEwen B.S. Metabolism of dehydroepiandrosterone by rat hippocampal cells in culture: possible role of aromatization and 7-hydroxylation in neuroprotection. J. Steroid Biochem. Mol. Biol. 2001, 78(4):313-317.
14. Morfin R., Starka L. Neurosteroid 7-hydroxylation products in the brain. Int. Rev. Neurobiol. 2001, 46:79-95.
15. Leskiewicz M., Jantas D., Budziszewska B., Lason W. Excitatory neurosteroids attenuate apoptotic and excitotoxic cell death in primary cortical neurons. J. Physiol. Pharmacol. 2008, 59(3):457-475.
16. Weaver C.E., Wu F.S., Gibbs T.T., Farb D.H. Pregnenolone sulfate exacerbates NMDA-induced death of hippocampal neurons. Brain Res. 1998, 803(1-2):129-136.
17. Shirakawa H., Katsuki H., Kume T., Kaneko S., Akaike A. Pregnenolone sulphate attenuates AMPA cytotoxicity on rat cortical neurons. Eur. J. Neurosci. 2005, 21(9):2329-2335.
18. Klein P., Herzog A.G. Hormonal effects on epilepsy in women. Epilepsia 1998, 39(Suppl. 8):S9-S16.
19. Frye C.A. The neurosteroid 3 alpha, 5 alpha-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 1995, 696(1-2):113-120.
20. Reddy D.S. Anticonvulsant activity of the testosterone-derived neurosteroid 3alpha-androstanediol. Neuroreport 2004, 15(3):515-518.
21. Kaminski R.M., Marini H., Kim W.J., Rogawski M.A. Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia 2005, 46(6):819-827.
22. Backstrom T., Andersson A., Andree L., Birzniece V., Bixo M., Bjorn I., Haage D., Isaksson M., Johansson I.M., Lindblad C., Lundgren P., Nyberg S., Odmark I.S., Stromberg J., Sundstrom-Poromaa I., Turkmen S., Wahlstrom G., Wang M., Wihlback A.C., Zhu D., Zingmark E. Pathogenesis in menstrual cycle-linked CNS disorders. Ann. N. Y. Acad. Sci. 2003, 1007:42-53.
23. Park-Chung M., Malayev A., Purdy R.H., Gibbs T.T., Farb D.H. Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites. Brain Res. 1999, 830(1):72-87.
24. Grosso S., Luisi S., Mostardini R., Farnetani M., Cobellis L., Morgese G., Balestri P., Petraglia F. Inter-ictal and post-ictal circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in epileptic children. Epilepsy Res. 2003, 54(1):29-34.
25. Galli R, Luisi M., Pizzanelli C., Monteleone P., Casarosa E., Iudice A., Murri L. Circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in women with partial epilepsy in the postcritical phase. Epilepsia 2001, 42(2):216-219.
26. Herzog A.G. Hormonal therapies: progesterone. Neurotherapeutics 2009, 6(2):383-391.
27. Reddy D.S. The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res. 2009, 85(1):1-30.
28. Reddy D.S., Rogawski M.A. Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics 2009, 6(2):392-401.
29. Willenberg H.S., Haase M., Papewalis C., Schott M., Scherbaum W.A., Bornstein S.R. Corticotropin-releasing hormone receptor expression on normal and tumorous human adrenocortical cells. Neuroendocrinology 2005, 82(5-6):274-281.
30. Ibanez L., Potau N., Marcos M.V., de Zegher F. Corticotropin-releasing hormone as adrenal androgen secretagogue. Pediatr. Res. 1999, 46(3):351-353.
31. Smith R., Mesiano S., Chan E.C., Brown S., Jaffe R.B. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J. Clin. Endocrinol. Metab. 1998, 83(8):2916-2920.
32. Mesiano S., Jaffe R.B. Developmental and functional biology of the primate fetal adrenal cortex. Endocr. Rev. 1997, 18(3):378-403.
33. Rainey W.E., Rehman K.S., Carr B.R. The human fetal adrenal: making adrenal androgens for placental estrogens. Semin. Reprod. Med. 2004, 22(4):327-336.
34. Brunet M., Rodamilans M., Martinez-Osaba M.J., Santamaria J., To-Figueras J., Torra M., Corbella J., Rivera F. Effects of long-term antiepileptic therapy on the catabolism of testosterone. Pharmacol. Toxicol. 1995, 76(6):371-375.
35. Reddy D.S. Mass spectrometric assay and physiological-pharmacological activity of androgenic neurosteroids. Neurochem. Int. 2008, 52(4-5):541-553.
36. Labrie F., Belanger A., Cusan L., Candas B. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J. Clin. Endocrinol. Metab. 1997, 82(8):2403-2409.
37. Putignano P., Kaltsas G.A., Satta M.A., Grossman A.B. The effects of anti-convulsant drugs on adrenal function. Horm. Metab. Res. 1998, 30(6-7):389-397.
38. Lossius M.I., Tauboll E., Mowinckel P., Morkrid L., Gjerstad L. Reversible effects of antiepileptic drugs on reproductive endocrine function in men and women with epilepsy-a prospective randomized double-blind withdrawal study. Epilepsia 2007, 48(10):1875-1882.
39. Isojarvi J.I., Lofgren E., Juntunen K.S., Pakarinen A.J., Paivansalo M., Rautakorpi I., Tuomivaara L. Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology 2004, 62(2):247-253.
40. Herzog A.G., Drislane F.W., Schomer D.L., Pennell P.B., Bromfield E.B., Kelly K.M., Farina E.L., Frye C.A. Differential effects of antiepileptic drugs on sexual function and reproductive hormones in men with epilepsy: interim analysis of a comparison between lamotrigine and enzyme-inducing antiepileptic drugs. Epilepsia 2004, 45(7):764-768.
41. Herzog A.G., Drislane F.W., Schomer D.L., Pennell P.B., Bromfield E.B., Dworetzky B.A., Farina E.L., Frye C.A. Differential effects of antiepileptic drugs on neuroactive steroids in men with epilepsy. Epilepsia 2006, 47(11):1945-1948.
42. Røste L.S., Tauboll E., Morkrid L., Bjornenak T., Saetre E.R., Morland T., Gjerstad L. Antiepileptic drugs alter reproductive endocrine hormones in men with epilepsy. Eur. J. Neurol. 2005, 12(2):118-124.
43. Macphee G.J., Larkin J.G., Butler E., Beastall G.H., Brodie M.J. Circulating hormones and pituitary responsiveness in young epileptic men receiving long-term antiepileptic medication. Epilepsia 1988, 29(4):468-475.
44. Rattya J., Pakarinen A.J., Knip M., Repo-Outakoski M., Myllyla V.V., Isojarvi J.I. Early hormonal changes during valproate or carbamazepine treatment: a 3-month study. Neurology 2001, 57(3):440-444.
45. Kwan P., Yip F.P., Hui A.C., Leung H., Ng P.W., Hui K.F., Chan I.H., Chan M.H., Lam C.W. Effects of valproate or lamotrigine monotherapy on the reproductive endocrine and insulin-related metabolic profile in Chinese adults with epilepsy: a prospective randomized study. Epilepsy Behav. 2009, 14(4):610-616.
46. Rattya J., Turkka J., Pakarinen A.J., Knip M., Kotila M.A., Lukkarinen O., Myllyla V.V., Isojarvi J.I. Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy. Neurology 2001, 56(1):31-36.
47. Stephen L.J, Kwan P., Shapiro D., Dominiczak M., Brodie M.J. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy. Epilepsia 2001, 42(8):1002-1006.
48. Stöffel-Wagner B., Bauer J., Flugel D., Brennemann W., Klingmuller D., Elger C.E. Serum sex hormones are altered in patients with chronic temporal lobe epilepsy receiving anticonvulsant medication. Epilepsia 1998, 39(11):1164-1173.
49. Svalheim S., Tauboll E., Luef G., Lossius A., Rauchenzauner M., Sandvand F., Bertelsen M., Morkrid L., Gjerstad L. Differential effects of levetiracetam, carbamazepine, and lamotrigine on reproductive endocrine function in adults. Epilepsy Behav. 2009, 16(2):281-287.
50. Bauer J., Stöffel-Wagner B., Flugel D., Kluge M., Schramm J., Bidlingmaier F., Elger C.E. Serum androgens return to normal after temporal lobe epilepsy surgery in men. Neurology 2000, 55(6):820-824.
51. Mikkonen K., Tapanainen P., Pakarinen A.J., Paivansalo M., Isojarvi J.I., Vainionpaa L.K. Serum androgen levels and testicular structure during pubertal maturation in male subjects with epilepsy. Epilepsia 2004, 45(7):769-776.
52. Hill M., Parizek A., Kanceva R., Duskova M., Velikova M., Kriz L., Klimkova M., Paskova A., Zizka Z., Matucha P., Meloun M., Starka L. Steroid metabolome in plasma from the umbilical artery, umbilical vein, maternal cubital vein and in amniotic fluid in normal and preterm labor. J. Steroid Biochem. Mol. Biol. 2010.
53. Hill M., Hampl R., Lukac D., Lapcik O., Pouzar V., Sulcova J. Elimination of cross-reactivity by addition of an excess of cross-reactant for radioimmunoassay of 17alpha-hydroxypregnenolone. Steroids 1999, 64(5):341-355.
54. Trygg J., Holmes E., Lundstedt T. Chemometrics in metabonomics. J. Proteome Res. 2007, 6(2):469-479.
55. Trygg J., Wold S. Orthogonal projections to latent structure. J. Chemometrics 2002, 16:119-128.
56. Murialdo G., Galimberti C.A., Fonzi S., Manni R., Costelli P., Parodi C., Torre F., Solinas G.P., Polleri A., Tartara A. Sex hormones, gonadotropins and prolactin in male epileptic subjects in remission: role of the epileptic syndrome and of antiepileptic drugs. Neuropsychobiology 1994, 30(1):29-36.
57. Isojarvi J.I, Repo M., Pakarinen A.J., Lukkarinen O., Myllyla V.V. Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsy. Epilepsia 1995, 36(4):366-370.
58. Starka L., Pospisilova H., Hill M. Free testosterone and free dihydrotestosterone throughout the life span of men. J. Steroid Biochem. Mol. Biol. 2009, 116(1-2):118-120.
59. Labrie F., Luu-The V., Lin S.X., Simard J., Labrie C., El-Alfy M., Pelletier G., Belanger A. Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease. J. Mol. Endocrinol. 2000, 25(1):1-16.
60. Herzog A.G. Psychoneuroendocrine aspects of temporolimbic epilepsy. Part I. Brain, reproductive steroids, and emotions. Psychosomatics 1999, 40(2):95-101.
61. Herzog A.G. Psychoneuroendocrine aspects of temporolimbic epilepsy. Part II: epilepsy and reproductive steroids. Psychosomatics 1999, 40(2):102-108.
62. Duncan S., Blacklaw J., Beastall G.H., Brodie M.J. Antiepileptic drug therapy and sexual function in men with epilepsy. Epilepsia 1999, 40(2):197-204.
63. Motta E., Rosciszewska D., Buntner B. Serum ACTH levels in patients treated for epilepsy. Neurol. Neurochir. Pol. 1994, 28(3):317-323.
64. Lapchak P.A., Chapman D.F., Nunez S.Y., Zivin J.A. Dehydroepiandrosterone sulfate is neuroprotective in a reversible spinal cord ischemia model: possible involvement of GABA(A) receptors. Stroke 2000, 31(8):1953-1956. discussion 1957.
65. Malayev A., Gibbs T.T., Farb D.H. Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids. Br. J. Pharmacol. 2002, 135(4):901-909.
66. Park-Chung M., Wu F.S., Farb D.H. 3 alpha-Hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons. Mol. Pharmacol. 1994, 46(1):146-150.
67. Nicol M.B., Hirst J.J., Walker D. Effects of pregnanolone on behavioural parameters and the responses to GABA(A) receptor antagonists in the late gestation fetal sheep. Neuropharmacology 1999, 38(1):49-63.